Search
01/01/2022
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up ?
Casali P.G., Blay J.Y., Abecassis N., Bajpai J., Bauer S., Biagini R., Bielack S., Bonvalot S., Boukovinas I., Bovee J.V.M.G., Boye K., Brodowicz T., Buonadonna A., De Álava E., Dei Tos A.P., Del Muro X.G., Dufresne A., Eriksson M., Fedenko A., Ferraresi V., Ferrari A., Frezza A.M., Gasperoni S., Gelderblom H., Gouin F., Grignani G., Haas R., Hassan A.B., Hindi N., Hohenberger P., Joensuu H., Jones R.L., Jungels C., Jutte P., Kasper B., Kawai A., Kopeckova K., Krákorová D.A., Le Cesne A., Le Grange F., Legius E., Leithner A., Lopez-Pousa A., Martin-Broto J., Merimsky O., Messiou C., Miah A.B., Mir O., Montemurro M., Morosi C., Palmerini E., Pantaleo M.A., Piana R., Piperno-Neumann S., Reichardt P., Rutkowski P., Safwat A.A., Sangalli C., Sbaraglia M., Scheipl S., Schöffski P., Sleijfer S., Strauss D., Strauss S.J., Hall K.S., Trama A., Unk M., van de Sande M.A.J., van der Graaf W.T.A., van Houdt W.J., Frebourg T., Gronchi A., Stacchiotti S., EURACAN and GENTURIS. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up ?. ANNALS OF ONCOLOGY. 2022; 33(1)DOI:10.1016/j.annonc.2021.09.005. PMID:34560242. IF:50.500(Q1/1D).
01/01/2022
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
Krolewiecki A., Enbiale W., Gandasegui J., van Lieshout L., Kepha S., Messa Junior A., Bengtson M., Gelaye W., Escola V., Martinez-Valladares M., Cambra-Pellejà M., Algorta J., Martí-Soler H., Fleitas P., Ballester M.R., Doyle S.R., Williams N.A., Legarda A., Mandomando I., Mwandawiro C., Muñoz J.. An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol. Gates Open Research. 2022; 6DOI:10.12688/gatesopenres.13615.1. PMID:. IF:(Q/D).
01/01/2022
Comment on: “Surgeon preimplantation macroscopic graft appraisal improves risk stratification of deceased kidney donors: a prospective study”
Piana A., Breda A., Pecoraro A., Prudhomme T., Territo A.. Comment on: “Surgeon preimplantation macroscopic graft appraisal improves risk stratification of deceased kidney donors: a prospective study”. Minerva Urology And Nephrology. 2022; 74(6)DOI:10.23736/S2724-6051.22.05178-3. PMID:36629811. IF:4.900(Q1/2D).
01/01/2022
Outcomes of ureteroscopy for management of stone disease in early and late childhood over a 15-year period
Sinha M., Pietropaolo A., Quiroz Madarriaga Y., de Knecht E.L., Bujons Tur A., Griffin S., Somani B.K.. Outcomes of ureteroscopy for management of stone disease in early and late childhood over a 15-year period. Therapeutic Advances in Urology. 2022; 14DOI:10.1177/17562872221141775. PMID:36568063. IF:2.000(Q3/7D).
01/01/2022
Three-dimensional Model-assisted Minimally Invasive Partial Nephrectomy: A Systematic Review with Meta-analysis of Comparative Studies
Piramide F., Kowalewski K.-F., Cacciamani G., Rivero Belenchon I., Taratkin M., Carbonara U., Marchioni M., De Groote R., Knipper S., Pecoraro A., Turri F., Dell'Oglio P., Puliatti S., Amparore D., Volpi G., Campi R., Larcher A., Mottrie A., Breda A., Minervini A., Ghazi A., Dasgupta P., Gozen A., Autorino R., Fiori C., Di Dio M., Gomez Rivas J., Porpiglia F., Checcucci E., European Association of Urology Young Academic Urologists and the European Secti. Three-dimensional Model-assisted Minimally Invasive Partial Nephrectomy: A Systematic Review with Meta-analysis of Comparative Studies. European Urology Oncology. 2022; 5(6)DOI:10.1016/j.euo.2022.09.003. PMID:36216739. IF:8.200(Q1/1D).
01/01/2022
Comment on “Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis” on behalf of the Young Academic Urologists – Urothelial Cancer Working Group
Afferi L., Gallioli A., Del Giudice F., Pradere B., Soria F., Moschini M.. Comment on “Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis” on behalf of the Young Academic Urologists – Urothelial Cancer Working Group. Minerva Urology And Nephrology. 2022; 74(6)DOI:10.23736/S2724-6051.22.05181-3. PMID:36629814. IF:4.900(Q1/2D).
01/01/2022
Robotic Radical Prostatectomy for Prostate Cancer in Renal Transplant Recipients: Results from a Multicenter Series
Marra G., Agnello M., Giordano A., Soria F., Oderda M., Dariane C., Timsit M.-O., Branchereau J., Hedli O., Mesnard B., Tilki D., Olsburgh J., Kulkarni M., Kasivisvanathan V., Breda A., Biancone L., Gontero P.. Robotic Radical Prostatectomy for Prostate Cancer in Renal Transplant Recipients: Results from a Multicenter Series. EUROPEAN UROLOGY. 2022; 82(6)DOI:10.1016/j.eururo.2022.05.024. PMID:35750583. IF:23.400(Q1/1D).
01/01/2022
Propofol sedation administered by cardiologists in echocardiography studies
Li C.-H., González-Salvado V., Bertolí E., Viladés D., Descalzo M., Carreras F., Leta R., Cinca J., Capellades H., Cueva L., Paniagua P.. Propofol sedation administered by cardiologists in echocardiography studies. Rec: Cardioclinics. 2022; 57(1)DOI:10.1016/j.rccl.2021.02.007. PMID:. IF:(Q/D).